Merck & Co., Inc. Logo

Merck & Co., Inc. (MRK)

TSX

Currency in CAD
34.86
+1.20 (+3.57%)

Closed

Aug 25, 2026

Day's Range

34.00
34.90

52 wk Range

17.66
34.90

Overview - MRK - Merck & Co., Inc.

Key Statistics

Valuation

Enterprise Value

571.86B

P/E (Trailing)

‪124.50‬

PEG Ratio

‪-0.95‬

Price / Sales (TTM)

‪8.26‬

Price / Book

‪12.68‬

EV / EBITDA

‪19.64‬

Profitability

Gross Margin

‪73.53%‬

Profit Margin

‪74.80%‬

Operating Margin

‪34.49%‬

Return on Assets

‪13.33%‬

Return on Equity

‪34.66%‬

Ownership

Shares Outstanding

2.46B

Price stats

50-Day Avg

‪28.70‬

200-Day Avg

‪26.93‬

Dividends

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - MRK - Merck & Co., Inc.

Peers - MRK - Merck & Co., Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on TSX.

Profile Summary - MRK - Merck & Co., Inc.

About

Merck & Co., Inc. is a leading global healthcare company specializing in the discovery, development, manufacturing, and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical segment features blockbuster drugs like Keytruda, a leading immuno-oncology treatment…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees73K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.